Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC and Secretome in severe ARDS
NCT07439848Phase 2Recruiting
- Sponsor
- Prodia Stem Cell Indonesia
- Start
- Dec 2023
- Primary completion
- Dec 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord mesenchymal stem cell injection in acute respiratory distress syndrome (ARDS), sponsored by Prodia Stem Cell Indonesia. Started Dec 2023; status: recruiting.
02
Drugs
umbilical cord mesenchymal stem cell injection
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT07439848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07439848.